BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33007755)

  • 1. Long-term survival in patients with primary intracranial germ cell tumors treated with surgery, platinum-based chemotherapy, and radiotherapy: a single-institution study.
    Shimizu H; Motomura K; Ohka F; Aoki K; Tanahashi K; Hirano M; Chalise L; Nishikawa T; Yamaguchi J; Yoshida J; Natsume A; Wakabayashi T
    J Neurosurg; 2020 Oct; 135(2):449-457. PubMed ID: 33007755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.
    Murray MJ; Bailey S; Heinemann K; Mann J; Göbel UK; Saran F; Hale JP; Calaminus G; Nicholson JC
    Int J Cancer; 2017 Aug; 141(3):621-635. PubMed ID: 28463397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.
    Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y
    J Neurosurg Pediatr; 2018 Nov; 23(3):317-324. PubMed ID: 30497152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal treatment strategy for intracranial germ cell tumors: a single institution analysis.
    Kanamori M; Kumabe T; Saito R; Yamashita Y; Sonoda Y; Ariga H; Takai Y; Tominaga T
    J Neurosurg Pediatr; 2009 Dec; 4(6):506-14. PubMed ID: 19951035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial germ cells tumour: a single institution experience in Argentina.
    Baroni LV; Oller A; Freytes CS; Sampor CV; Pinto N; Fernandez NP; Rugilo C; Lubieniecki F; Zubizarreta P; Alderete D
    J Neurooncol; 2021 Apr; 152(2):363-372. PubMed ID: 33660119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcome and long-term follow-up of central nervous system germ cell tumor using upfront chemotherapy with subsequent photon or proton radiation therapy: a single tertiary center experience of 127 patients.
    Hong KT; Lee DH; Kim BK; An HY; Choi JY; Phi JH; Cheon JE; Kang HJ; Kim SK; Kim JY; Park SH; Kim IH; Shin HY
    BMC Cancer; 2020 Oct; 20(1):979. PubMed ID: 33036578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
    Calaminus G; Frappaz D; Kortmann RD; Krefeld B; Saran F; Pietsch T; Vasiljevic A; Garre ML; Ricardi U; Mann JR; Göbel U; Alapetite C; Murray MJ; Nicholson JC
    Neuro Oncol; 2017 Nov; 19(12):1661-1672. PubMed ID: 29048505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.
    Satomi K; Takami H; Fukushima S; Yamashita S; Matsushita Y; Nakazato Y; Suzuki T; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Yoshimoto K; Tamura K; Maehara T; Sakai K; Sugiyama K; Yokogami K; Takeshima H; Nonaka M; Asai A; Ushijima T; Matsutani M; Nishikawa R; Ichimura K
    Neuro Oncol; 2022 May; 24(5):834-846. PubMed ID: 34698864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracranial germ cell tumors: a single-institution experience.
    Khafaga Y; El Weshi A; Nazmy M; Hassounah M; Alshail E; Moussa E; Allam A; Alkofide A; Jamshed A; ELhusseiny G; Ezzat I; Jenkin D
    Ann Saudi Med; 2012; 32(4):359-65. PubMed ID: 22705605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management and long-term outcomes of intracranial giant cell tumors: a single-institution experience with a systematic review.
    Weng JC; Li D; Wang L; Wu Z; Wang JM; Li GL; Jia W; Zhang LW; Zhang JT
    J Neurosurg; 2018 Oct; 131(3):695-705. PubMed ID: 30497189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of intracranial non-germinomatous germ cell tumors: a retrospective Asian multinational study on treatment strategies and prognostic factors.
    Hong KT; Han JW; Fuji H; Byun HK; Koh KN; Wong RX; Lee HL; Yoon HI; Lee JH; Phi JH; Kim SK; Kim DS; Lyu CJ; Choi JY; Kang HJ; Chen YW; Lee YY; Im HJ; Ra YS; Do Ahn S; Low SYY; Looi WS; Park HJ; Suh YG; Suh CO; Wang KC; Tan EEK; Wong TT; Kim JY
    J Neurooncol; 2022 Oct; 160(1):41-53. PubMed ID: 36045266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy.
    Breen WG; Blanchard MJ; Rao AN; Daniels DJ; Buckner JC; Laack NNI
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28695992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the Treatment Strategies of Intracranial Germ Cell Tumors: Focusing on Radiotherapy.
    Kim JY; Park J
    J Korean Neurosurg Soc; 2015 May; 57(5):315-22. PubMed ID: 26113957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: Survival analysis and impact of salvage re-irradiation.
    de Rezende ACP; Weltman E; Chen MJ; Helito JK; de Carvalho ÍT; Sakuraba RK; Silva NS; Cappellano AM; Hamerschlak N
    PLoS One; 2019; 14(12):e0226350. PubMed ID: 31860688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of Biopsy-Proven Sellar Germ Cell Tumors: Nine Years' Experience in a Single Center.
    Zhang Y; Zhu H; Deng K; Ma W; Wang Y; Sun J; Lian X; Pan H; Wang R; Yao Y
    World Neurosurg; 2018 Apr; 112():e229-e239. PubMed ID: 29325960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial non-germinomatous germ cell tumors in children and adolescents: how can the experience from an uppermiddle-income country contribute to the worldwide effort to improve outcomes?
    Cappellano AM; Dassi N; Mançano BM; Epelman S; Almeida DB; Cavalheiro S; Dastoli PA; Alves MTS; Nicacio JM; Costa MDS; Silva FA; Aguiar SS; Figueiredo ML; Chen M; Silva NS; Finlay JL
    Front Oncol; 2024; 14():1308128. PubMed ID: 38500657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial Germ Cell Tumors in Adolescents and Young Adults: A 40-Year Multi-Institutional Review of Outcomes.
    Lo AC; Hodgson D; Dang J; Tyldesley S; Bouffet E; Bartels U; Cheng S; Hukin J; Bedard PL; Goddard K; Laperriere N
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):269-278. PubMed ID: 31654785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors.
    Kim JW; Kim WC; Cho JH; Kim DS; Shim KW; Lyu CJ; Won SC; Suh CO
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):625-31. PubMed ID: 22420971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors.
    Mokhtech M; Rotondo RL; Bradley JA; Sandler ES; Nanda R; Logie N; Aldana PR; Morris CG; Indelicato DJ
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26997. PubMed ID: 29380526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.